In esophageal squamous cell carcinoma, hepatocellular carcinoma, and epithelial ovarian cancer, high UCHL5 expression correlated with cancer recurrence and reduced patient survival [16–18]. This evidence concerns the gene UCHL5 and esophageal squamous cell carcinoma.